Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide)
pCPA File Number:
21078
Negotiation Status:
Concluded with an LOI
Indication(s):
HIV-1 Infection
Sponsor/Manufacturer:
Gilead Sciences Canada Inc.
CDA-AMC Project Number:
SR0567-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: